Emdeki Utama Tbk PT
IDX:MDKI
Emdeki Utama Tbk PT
IDX:MDKI
Price:
169
IDR
-0.59%
Market Closed
Market Cap:
427.6B
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
MDKI Alert
Emdeki Utama Tbk PT
169
-1 (-0.59%)
| 52 Week Range |
169
208
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Emdeki Utama Tbk PT
Balance Sheet
Balance Sheet Decomposition
Emdeki Utama Tbk PT
Emdeki Utama Tbk PT
| Current Assets | 370.3B |
| Cash & Short-Term Investments | 201B |
| Receivables | 19.2B |
| Other Current Assets | 150B |
| Non-Current Assets | 662.5B |
| Long-Term Investments | 590m |
| PP&E | 625.3B |
| Intangibles | 28.6B |
| Other Non-Current Assets | 8.1B |
| Current Liabilities | 44.5B |
| Accounts Payable | 12B |
| Accrued Liabilities | 6.4B |
| Short-Term Debt | 14.9B |
| Other Current Liabilities | 11.1B |
| Non-Current Liabilities | 49.2B |
| Long-Term Debt | 2.8B |
| Other Non-Current Liabilities | 46.5B |
Balance Sheet
Emdeki Utama Tbk PT
Emdeki Utama Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
15 193
|
41 738
|
64 051
|
200 515
|
203 117
|
43 041
|
230 641
|
233 678
|
185 968
|
221 816
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
43 041
|
66 922
|
71 878
|
42 368
|
51 122
|
|
| Cash Equivalents |
15 193
|
41 738
|
64 051
|
200 515
|
203 117
|
0
|
163 719
|
161 800
|
143 600
|
170 694
|
|
| Short-Term Investments |
0
|
2 601
|
117
|
121
|
0
|
155 606
|
163 719
|
161 800
|
143 600
|
0
|
|
| Total Receivables |
25 975
|
15 675
|
12 203
|
20 691
|
15 185
|
21 242
|
25 848
|
29 679
|
50 820
|
32 104
|
|
| Accounts Receivables |
12 290
|
15 341
|
11 943
|
15 503
|
14 471
|
19 891
|
24 589
|
28 881
|
49 912
|
31 147
|
|
| Other Receivables |
13 685
|
334
|
260
|
5 188
|
714
|
1 351
|
1 259
|
798
|
908
|
957
|
|
| Inventory |
59 886
|
30 337
|
28 747
|
64 098
|
59 683
|
73 267
|
63 340
|
70 180
|
124 459
|
135 004
|
|
| Other Current Assets |
7 595
|
6 103
|
4 114
|
8 830
|
4 393
|
3 748
|
2 830
|
9 038
|
4 743
|
1 000
|
|
| Total Current Assets |
111 250
|
99 667
|
109 232
|
294 255
|
282 378
|
296 904
|
322 659
|
342 575
|
365 990
|
389 924
|
|
| PP&E Net |
184 621
|
167 371
|
162 678
|
527 615
|
593 523
|
592 584
|
619 485
|
609 429
|
639 459
|
629 527
|
|
| PP&E Gross |
184 621
|
167 371
|
162 678
|
527 615
|
593 523
|
592 584
|
619 485
|
609 429
|
639 459
|
629 527
|
|
| Accumulated Depreciation |
251 670
|
266 175
|
274 873
|
15 212
|
2 367
|
16 425
|
3 002
|
17 850
|
3 903
|
20 681
|
|
| Goodwill |
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
|
| Note Receivable |
6 535
|
0
|
0
|
5 897
|
8 857
|
2 960
|
730
|
421
|
3 218
|
3 218
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
161
|
348
|
294
|
710
|
539
|
497
|
|
| Other Long-Term Assets |
8 459
|
7 638
|
31 250
|
11 104
|
566
|
2 419
|
1 936
|
3 685
|
8 143
|
12 801
|
|
| Other Assets |
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
28 580
|
|
| Total Assets |
339 445
N/A
|
303 256
-11%
|
331 740
+9%
|
867 451
+161%
|
914 065
+5%
|
923 795
+1%
|
973 684
+5%
|
985 400
+1%
|
1 045 929
+6%
|
1 064 547
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
40 282
|
29 298
|
18 820
|
34 026
|
20 819
|
20 211
|
17 523
|
18 695
|
42 617
|
28 204
|
|
| Accrued Liabilities |
18 131
|
10 341
|
12 923
|
18 557
|
11 394
|
9 902
|
9 514
|
9 498
|
10 600
|
9 782
|
|
| Short-Term Debt |
17 375
|
20 375
|
34
|
0
|
4 000
|
4 000
|
0
|
10 000
|
9 720
|
15 000
|
|
| Current Portion of Long-Term Debt |
26 681
|
21 093
|
274
|
107
|
0
|
0
|
89
|
100
|
1 598
|
3 288
|
|
| Other Current Liabilities |
2 789
|
10 043
|
19 567
|
13 387
|
4 029
|
7 996
|
7 633
|
5 295
|
3 485
|
7 108
|
|
| Total Current Liabilities |
105 258
|
91 150
|
51 618
|
66 077
|
40 242
|
42 109
|
34 759
|
43 588
|
68 020
|
63 382
|
|
| Long-Term Debt |
71 033
|
49 957
|
107
|
0
|
0
|
0
|
213
|
112
|
1 932
|
2 759
|
|
| Deferred Income Tax |
0
|
0
|
0
|
879
|
9 721
|
10 757
|
8 021
|
13 010
|
14 206
|
14 126
|
|
| Minority Interest |
1 689
|
1 481
|
4 830
|
10 737
|
12 131
|
12 591
|
13 399
|
13 660
|
14 452
|
14 821
|
|
| Other Liabilities |
35 822
|
29 718
|
36 739
|
38 032
|
32 650
|
36 531
|
40 711
|
23 396
|
21 553
|
19 371
|
|
| Total Liabilities |
213 802
N/A
|
172 306
-19%
|
93 294
-46%
|
115 725
+24%
|
94 744
-18%
|
101 988
+8%
|
97 103
-5%
|
93 766
-3%
|
120 163
+28%
|
114 459
-5%
|
|
| Equity | |||||||||||
| Common Stock |
7 000
|
7 000
|
7 000
|
180 725
|
253 015
|
253 015
|
253 015
|
253 015
|
253 015
|
253 015
|
|
| Retained Earnings |
127 500
|
133 129
|
219 820
|
89 163
|
94 404
|
99 584
|
119 004
|
130 672
|
146 380
|
172 932
|
|
| Additional Paid In Capital |
0
|
0
|
25 034
|
174 981
|
105 636
|
105 636
|
102 691
|
102 691
|
102 691
|
102 691
|
|
| Other Equity |
8 857
|
9 179
|
13 408
|
306 857
|
366 266
|
363 572
|
401 871
|
405 256
|
423 680
|
421 450
|
|
| Total Equity |
125 643
N/A
|
130 950
+4%
|
238 446
+82%
|
751 726
+215%
|
819 321
+9%
|
821 807
+0%
|
876 581
+7%
|
891 634
+2%
|
925 766
+4%
|
950 088
+3%
|
|
| Total Liabilities & Equity |
339 445
N/A
|
303 256
-11%
|
331 740
+9%
|
867 451
+161%
|
914 065
+5%
|
923 795
+1%
|
973 684
+5%
|
985 400
+1%
|
1 045 929
+6%
|
1 064 547
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
98
|
98
|
98
|
2 530
|
2 530
|
2 530
|
2 530
|
2 530
|
2 530
|
2 530
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
